A new drug which targets cancer cells is now available in Australia for men battling the most deadly form of prostate cancer.

Darolutamide prevents processes that allow cancer cells to multiply and divide, and has hit the market after passing a series of large clinical trials.

Prostate Cancer Foundation of Australia CEO Anne Savage told Ian Blackley on 6PR Afternoons developments in medication are making a marked effect on prostate cancer rates in Australia.

Press PLAY to hear more about the work being done to fight prostate cancer